Short-course Radiotherapy Combined With Serplulimab and Chemotherapy as Neoadjuvant Treatment for Resectable ESCC

Conditions

• Esophageal Squamous Cell Carcinoma (ESCC)

Interventions

• DRUG: Serplulimab

Sponsor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology